Morphine for later stage COPD patients not on hospice

April 9th, 2021

Does regular, low-dose, oral sustained-release morphine improve disease-specific health status or cause respiratory adverse effects in patients with moderate to very severe chronic breathlessness due to advanced chronic obstructive pulmonary disease? Digging in on the latest study.

Share | Download(Loading)
Podbean App

Play this podcast on Podbean App